TerminatedPhase 2NCT04984616

Atorvastatin on Inflammation and Cardiac Function in Chronic Chagas Disease

Studying American trypanosomiasis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Juan D. Maya
Principal Investigator
Juan D. Maya, Ph.D.
Full Professor
Intervention
40 mg Atorvastatin/day for 120 days P.O.(drug)
Enrollment
300 enrolled
Eligibility
18-50 years · All sexes
Timeline
2021 – 2024

Study locations (4)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04984616 on ClinicalTrials.gov

Other trials for American trypanosomiasis

Additional recruiting or active studies for the same condition.

See all trials for American trypanosomiasis →

← Back to all trials